Susquehanna International Group’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Sell |
134,208
-26,930
| -17% | -$258K | ﹤0.01% | 2878 |
|
|
2025
Q1 | $1.01M | Sell |
161,138
-74,266
| -32% | -$466K | ﹤0.01% | 3339 |
|
|
2024
Q4 | $1.91M | Buy |
235,404
+56,734
| +32% | +$461K | ﹤0.01% | 2042 |
|
|
2024
Q3 | $3.23M | Buy |
+178,670
| New | +$3.23M | ﹤0.01% | 1430 |
|
|
2024
Q2 | – | Sell |
-59,437
| Closed | -$631K | – | 6365 |
|
|
2024
Q1 | $631K | Buy |
59,437
+7,124
| +14% | +$75.7K | ﹤0.01% | 3226 |
|
|
2023
Q4 | $478K | Buy |
+52,313
| New | +$478K | ﹤0.01% | 3928 |
|
|
2023
Q3 | – | Sell |
-63,408
| Closed | -$908K | – | 6151 |
|
|
2023
Q2 | $908K | Sell |
63,408
-83,008
| -57% | -$1.19M | ﹤0.01% | 2852 |
|
|
2023
Q1 | $1.05M | Buy |
146,416
+119,849
| +451% | +$856K | ﹤0.01% | 2829 |
|
|
2022
Q4 | $298K | Buy |
26,567
+2,668
| +11% | +$29.9K | ﹤0.01% | 3902 |
|
|
2022
Q3 | $265K | Buy |
+23,899
| New | +$265K | ﹤0.01% | 4393 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6452 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6332 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5885 |
|
|
2021
Q2 | – | Sell |
-26,505
| Closed | -$996K | – | 5765 |
|
|
2021
Q1 | $996K | Buy |
26,505
+2,246
| +9% | +$84.4K | ﹤0.01% | 3009 |
|
|
2020
Q4 | $806K | Buy |
+24,259
| New | +$806K | ﹤0.01% | 2846 |
|